Prevention & lipidsCross-sectional study
Recommended and observed statin use among US adults with and without cancer
- Cross-sectional study
- NHANES 2013-18
Authors' conclusion
Our finding highlights the importance of optimization of CV health in patients with cancer, as individuals with cancer were more likely to have a Class 1 indication for statin treatment when compared with individuals without cancer.
Study context
- Population
- US adults, National Health and Nutrition Examination Survey (2013–18)
- Participants
- 17,050 adults
- Exposure
- Cancer vs no cancer
- Outcome
- Prevalence of Class 1 statin recommendations and statin use
Main finding
As reported in the abstract
Statin use among those with a statin indication
P < 0.001
Observational data: associations, not effects.
Further findings
Statin indication, stratified by age
- Cancer more likely to have a secondary prevention indication, but not a primary prevention indication
Statin use by demographic subgroup
- Higher statin use with cancer noted among younger individuals, ethnic minorities and those with lower family income
Original publication
Recommended and observed statin use among US adults with and without cancer. Eur J Prev Cardiol. Published 9 February 2024. doi:10.1093/eurjpc/zwae057
Summarised from the published abstract; every number is checked against it